Molecular oncology - Perspectives in lung cancer

Lung Cancer

Volumn 45, Issue SUPPL. 2, 2004, Pages

  Huber, R M ^a   Stratakis, D F ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Lung cancer; Molecular targets; Prognosis; Treatment

Indexed keywords

2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; 3 BENZYL 7 CYANO 2,3,4,5 TETRAHYDRO 1 (1H IMIDAZOL 4 YLMETHYL) 4 (2 THIENYLSULFONYL) 1H 1,4 BENZODIAZEPINE; AE 941; ANGIOGENIC FACTOR; ANGIOSTATIN; ANTINEOPLASTIC AGENT; BEVACIZUMAB; BORTEZOMIB; CELECOXIB; CETUXIMAB; CGP 69846A; CISPLATIN; DOCETAXEL; ENDOSTATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB; GEMCITABINE; IRINOTECAN; ISIS 2503; K RAS PROTEIN; LONAFARNIB; MATRIX METALLOPROTEINASE; MONOCLONAL ANTIBODY LM 609; NONSTEROID ANTIINFLAMMATORY AGENT; ONYX 015; PROTEIN BCL 2; PROTEIN P53; RETINOBLASTOMA PROTEIN; ROFECOXIB; SORAFENIB; SUNITINIB; TIPIFARNIB; UNINDEXED DRUG; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; CANCER DIAGNOSIS; CANCER GENETICS; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CELL PROLIFERATION; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; DRUG EFFICACY; DRUG TARGETING; EARLY DIAGNOSIS; GENOMICS; HIGH RISK POPULATION; HUMAN; IMAGE ANALYSIS; LUNG CANCER; LUNG CARCINOGENESIS; MODEL; MOLECULAR BIOLOGY; ONCOLOGY; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; SIGNAL TRANSDUCTION; SPUTUM CYTODIAGNOSIS; STROMA; SURVIVAL RATE; SURVIVAL TIME; THORAX RADIOGRAPHY; TUMOR CELL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; HUMANS; LUNG NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 8444248738     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.07.973     Document Type: Conference Paper

References (28)

1. Marcus P.M., Bergstralh E.J., and Fagerstrom R.M. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up J Natl Cancer Inst 92 16 2000 1308 1316
2. Lenhard R.E. Jr., Waalkes T.P., and Herring D. Evaluation of the clinical management of cancer patients. A pilot study J Am Med Assoc 250 24 1983 3310 3316
3. Pastorino U., Bellomi M., and Landoni C. Early Lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results Lancet 362 2003 593 597
4. Tockman M.S., Mulshine J.L., and Piantadosi S. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression Clin Cancer Res 12 1997 2237 2246
5. Tockman M.S., Gupta P.K., and Myers J.D. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection J Clin Onco 6 1988 1685 1693
6. Miozzo M., Sozzi G., and Musso K. Microsatellite alterations in bronchial and sputum specimens of lung cancer patients Cancer Res 56 1996 2285 2288
7. Jheon S., Hyun D.S., and Lee S.C. Lung cancer detection by a RT-nested PCR using MAGE A1-6 common primers Lung Cancer 43 2004 29 37
8. Gessner C., Kuhn H., and Toepfer K. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients Lung Cancer 43 2004 215 222
9. Polyak K., and Riggins G.J. Gene discovery using the serial analysis of gene expression technique: implications for cancer research J Clin Onco 19 2001 2948 2958
10. Aitman T.J. DNA microarrays in medical practice Br Med J 323 2001 611 615
11. Yanagisawa K., Shyr Y., and Xu B.J. Proteomic patterns of tumour subsets in non-small-cell lung cancer Lancet 362 2003 433 439
12. van Zandwijk N., and Hirsch F.R. Chemoprevention of lung cancer: current status and future prospects Lung Cancer 42 2003 S71 S79
13. Khuri F.R. Primary and secondary prevention of non-small-cell lung cancer: the SPORE Trials of Lung Cancer Prevention Clin Lung Cancer 5 2003 S36 S40
14. Hasturk S., Kemp B., and Kalapurakal S.K. Expression of cycto-oxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma Cancer 94 2002 1023 1031
15. Fischer J.R., and Lahm H. Validation of molecular and immunological factors with predictive importance in lung cancer Lung Cancer 45 Suppl 2 2004 S151 S161
16. Steels E., Paesmans M., Berghmans T., Branle F., Lemaitre F., Mascaux C., Meert A.P., Vallot F., Lafitte J.J., and Sculier J.P. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis Eur Respir J 18 2001 705 719
17. Brambilla C., and Spiro S. Highlights in lung cancer Eur Respir J 18 2001 617 618
18. Fontanini G., Faviana P., and Lucchi M. A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma Br J Cancer 86 2002 558 563
19. Slebos R.J., Kibbelaar R.E., and Dalesio O. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung N Engl J Med 323 1990 561 565
20. Passtick B., Kubuschok B., and Izbicki J.R. Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer Ann Thorac Surg 68 1999 2053 2058
21. Osaki T., Oyama T., and Gu C.D. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer J Clin Oncol 20 2002 2930 2936
22. Rosell R., Taron M., and O'Brate A. Predictive molecular markers in non-small cell lung cancer Curr Opin Oncol 13 2001 101 109
23. Whiteside M.A., Chen D.T., and Desmond R.A. A novel time-course cDNA micro-array analysis method identifies genes associated with the development of cisplatin resistance Oncogene 23 2004 744 752
24. Cappuzzo F., Ardizzoni A., and Soto-Parra H. Epidermal growth factor receptor targeted therapy by ZD1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC) Lung Cancer 41 2003 227 231
25. Su J.M., Wei Y.O., and Tian L. Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2 Cancer Res 63 2003 600 607
26. Reinmuth N., Mesters R.M., and Bieker R. Signal transduction pathways as novel therapy targets in lung cancer Lung cancer 45 Suppl 2 2004 S177 S186
27. Baumann M., Krause M., and Zips D. Molecular targeting in radiotherapy of lung cancer Lung Cancer 45 Suppl 2 2004 S187 S197
28. Micke P., and Östman A. Tumour-stroma interaction: Cancerassociated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 45 Suppl 2 2004 S163 S175